HLNNYSEPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31Also trades as HLNCF
Haleon plc
Financials through fiscal 2025, year ended Dec 31, 2025
$10.14+0.01 (+0.10%)
Close on Oct 19, 2026
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
596M
Shares held, 13F filers
Institutional holders
639
86 new, 57 sold out
Net institutional buying
28M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 745,718,619 | 8.50% | 13G (passive) amendment | Jun 30, 2026 |
| Wellington Management Group LLP | 443,046,686 | 5.00% | 13G (passive) amendment | Dec 31, 2025 |
| Dodge & Cox | 233,276,589 | 6.50% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HLN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Dodge & Cox | 149,934,507 | – | $1.40B | +3,394,844 | 0.73% |
| FMR LLC | 120,991,250 | – | $1.13B | +7,022,091 | 0.05% |
| Clearbridge Investments, LLC | 32,342,126 | – | $301.75M | +623,401 | 0.25% |
| Morgan Stanley | 19,461,762 | – | $181.58M | +295,509 | 0.01% |
| Harris Associates L P | 16,833,252 | – | $157.05M | +1,801,211 | 0.21% |
| Harding Loevner LP | 15,414,796 | – | $147.82M | −297,754 | 1.39% |
| Nuveen, LLC | 15,332,859 | – | $143.06M | +6,633,766 | 0.03% |
| Arrowstreet Capital, Limited Partnership | 14,181,817 | – | $132.32M | −492,701 | 0.06% |
| Bank Of America Corp /De/ | 10,850,097 | – | $101.23M | −84,131 | 0.01% |
| JPMorgan Chase & Co | 10,824,395 | – | $100.99M | +2,544,927 | 0.01% |
| Point72 Asset Management, L.P. | 9,264,255 | – | $86.44M | +2,690,217 | 0.10% |
| First Eagle Investment Management, LLC | 8,449,712 | – | $78.84M | +4,417,069 | 0.07% |
| Raymond James Financial Inc | 7,278,875 | – | $67.91M | +1,014,834 | 0.02% |
| Norges Bank | 7,175,000 | – | $66.94M | New | 0.01% |
| Jones Financial Companies Lllp | 7,116,095 | – | $65.75M | −1,970,433 | 0.03% |
| Aristotle Capital Management, LLC | 7,090,436 | – | $66.15M | −573,078 | 0.14% |
| Douglas Lane & Associates, LLC | 6,692,390 | – | $62.44M | −1,393 | 0.85% |
| Natixis Advisors, L.P. | 6,652,349 | – | $62.07K | −2,545,950 | 0.07% |
| Envestnet Asset Management Inc | 6,276,154 | – | $58.56M | −758,624 | 0.01% |
| Goldman Sachs Group Inc | 5,394,442 | – | $50.33M | −733,010 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 639 | 596M | 86 / 212 | 214 / 57 | 61M | 33M |
| Q1 2026 | 625 | 568M | 88 / 214 | 178 / 65 | 67M | 65M |
| Q4 2025 | 609 | 566M | 92 / 229 | 155 / 70 | 74M | 66M |
| Q3 2025 | 600 | 562M | 69 / 161 | 240 / 88 | 39M | 58M |
| Q2 2025 | 627 | 581M | 85 / 219 | 174 / 48 | 59M | 48M |
| Q1 2025 | 599 | 570M | 54 / 192 | 206 / 55 | 58M | 217M |
| Q4 2024 | 610 | 734M | 99 / 201 | 175 / 68 | 249M | 31M |
| Q3 2024 | 588 | 521M | 71 / 181 | 198 / 55 | 23M | 24M |
| Q2 2024 | 581 | 524M | 57 / 217 | 180 / 65 | 65M | 65M |
| Q1 2024 | 598 | 524M | 72 / 199 | 182 / 54 | 159M | 35M |
| Q4 2023 | 591 | 401M | 91 / 180 | 187 / 60 | 38M | 28M |
| Q3 2023 | 569 | 391M | 61 / 179 | 177 / 62 | 41M | 27M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of HLN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Dodge & Cox Stock Fund | 107,251,461 | – | $1.00B | 0.85% | Jun 30, 2026 |
| Fidelity Series Large Cap Stock Fund | 18,874,236 | – | $176.10M | 0.61% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 14,710,159 | – | $133.27M | 0.05% | May 31, 2026 |
| Oakmark International Fund | 13,300,500 | – | $124.09M | 1.00% | Jun 30, 2026 |
| Fidelity Growth and Income Portfolio | 12,004,220 | – | $118.48M | 0.80% | Jul 31, 2026 |
| Dodge & Cox Balanced Fund | 11,685,813 | – | $109.03M | 0.74% | Jun 30, 2026 |
| College Retirement Equities Fund - Total Global Stock Account | 9,218,243 | – | $86.01M | 0.06% | Jun 30, 2026 |
| Fidelity Large Cap Stock Fund | 6,840,625 | – | $67.52M | 0.64% | Jul 31, 2026 |
| Bridge Builder Large Cap Value Fund | 4,975,893 | – | $46.43M | 0.16% | Jun 30, 2026 |
| Fidelity Advisor Capital Development Fund | 4,150,000 | – | $38.72M | 0.61% | Jun 30, 2026 |
| Fidelity Mega Cap Stock Fund | 3,960,733 | – | $36.95M | 0.53% | Jun 30, 2026 |
| ClearBridge Large Cap Value Fund | 3,117,021 | – | $30.76M | 1.27% | Jul 31, 2026 |
| VanEck Pharmaceutical ETF | 2,913,351 | – | $27.18M | 3.09% | Jun 30, 2026 |
| Nuveen Multi Cap Value Fund | 2,733,619 | – | $25.50M | 2.03% | Jun 30, 2026 |
| VIP Growth and Income Portfolio | 2,243,094 | – | $20.93M | 0.73% | Jun 30, 2026 |
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| (US) Trust GlaxoSmithKline Affiliate | Dec 29, 2023 | 8,527,104 | $70.60M | Dec 27, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |
| Master Grantor Trust GSK Affiliate | Dec 5, 2023 | 404,599 | $3.47M | Dec 5, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |
| Employee Trust GlaxoSmithKline Affiliate | Nov 3, 2023 | 173,611 | $1.38M | Nov 6, 2023 | The American Depositary Shares were allocated as part of the spin-off of Haleon plc from GSK plc |